Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RECCE PHARMACEUTICALS LTD Share Issue/Capital Change 2024

Nov 20, 2024

65669_rns_2024-11-20_ddd0c34e-8736-4c8c-97b5-e4609fc98e27.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Date of this announcement

Thursday November 21, 2024

The +securities the subject of this notification are:

Total number of +securities to be issued/transferred +Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

ASX +securitycode Security description Total number of+securities to beissued/transferred Issue date
New class - codeto be confirmed OPTION EXPIRING 14-NOV-2029 EX $0.80 11,500,000 14/11/2024

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type

ACN

Registration number

124849065

1.3 ASX issuer code RCE

1.4 The announcement is 1.5 Date of this announcement New announcement

21/11/2024

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code ("new class")

Part 3C - number and type of +securities the subject of this notification (new class)

ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 14-NOV-2029 EX $0.80
+Security typeOptions ISIN code
Date the +securities the subject of this notification were issued14/11/2024
Will all the +securities issued in this class rank equally in all respects from their issue date?Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?YesProvide details of the KMP or +associates being issued +securities.
Name of KMP Name of registered holder Number of +securities
John Prendergast Same 2,650,000
James Graham Same 3,000,000
Michele Dilizia Same 1,600,000
Justin Ward Same 1,000,000
Alan Dunton Same 2,250,000
Alistair McKeough Amabel Pty Limited 1,000,000

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1? No

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02863790-6A1230025

Options Details

+Security currency AUD - Australian Dollar Exercise price AUD 0.80000000 Expiry date 14/11/2029

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option

RCE : ORDINARY FULLY PAID

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02863790-6A1230025

Any other information the entity wishes to provide about the +securities the subject of this notification

Issue of unlisted options to Directors of the Company under the Company's Employee Incentive Plan as approved by shareholders at the Annual General Meeting held on 6 November 2024.

Issue details

Number of +securities

11,500,000

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)

ASX +security code and description Total number of+securities on issue
RCE : ORDINARY FULLY PAID 231,871,617

4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)

ASX +security code and description Total number of+securities on issue
RCEAH : PERFORMANCE SHARES 8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56 435,000
RCEAO : OPTION EXPIRING 07-NOV-2029 EX $0.56 2,690,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 1,125,000
RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 8,415,000
New class - code to be confirmed : OPTION EXPIRING 14-NOV-2029 EX $0.80 11,500,000

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

14